BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

978 related articles for article (PubMed ID: 23389445)

  • 1. APOBEC3B is an enzymatic source of mutation in breast cancer.
    Burns MB; Lackey L; Carpenter MA; Rathore A; Land AM; Leonard B; Refsland EW; Kotandeniya D; Tretyakova N; Nikas JB; Yee D; Temiz NA; Donohue DE; McDougle RM; Brown WL; Law EK; Harris RS
    Nature; 2013 Feb; 494(7437):366-70. PubMed ID: 23389445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
    Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
    Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
    Nikkilä J; Kumar R; Campbell J; Brandsma I; Pemberton HN; Wallberg F; Nagy K; Scheer I; Vertessy BG; Serebrenik AA; Monni V; Harris RS; Pettitt SJ; Ashworth A; Lord CJ
    Br J Cancer; 2017 Jun; 117(1):113-123. PubMed ID: 28535155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
    Harris RS
    Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma.
    Leonard B; Hart SN; Burns MB; Carpenter MA; Temiz NA; Rathore A; Vogel RI; Nikas JB; Law EK; Brown WL; Li Y; Zhang Y; Maurer MJ; Oberg AL; Cunningham JM; Shridhar V; Bell DA; April C; Bentley D; Bibikova M; Cheetham RK; Fan JB; Grocock R; Humphray S; Kingsbury Z; Peden J; Chien J; Swisher EM; Hartmann LC; Kalli KR; Goode EL; Sicotte H; Kaufmann SH; Harris RS
    Cancer Res; 2013 Dec; 73(24):7222-31. PubMed ID: 24154874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational impact of APOBEC3A and APOBEC3B in a human cell line and comparisons to breast cancer.
    Carpenter MA; Temiz NA; Ibrahim MA; Jarvis MC; Brown MR; Argyris PP; Brown WL; Starrett GJ; Yee D; Harris RS
    PLoS Genet; 2023 Nov; 19(11):e1011043. PubMed ID: 38033156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B.
    Akre MK; Starrett GJ; Quist JS; Temiz NA; Carpenter MA; Tutt AN; Grigoriadis A; Harris RS
    PLoS One; 2016; 11(5):e0155391. PubMed ID: 27163364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
    Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
    mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
    Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
    Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyomavirus T Antigen Induces
    Starrett GJ; Serebrenik AA; Roelofs PA; McCann JL; Verhalen B; Jarvis MC; Stewart TA; Law EK; Krupp A; Jiang M; Martens JWM; Cahir-McFarland E; Span PN; Harris RS
    mBio; 2019 Feb; 10(1):. PubMed ID: 30723127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
    Tokunaga E; Yamashita N; Tanaka K; Inoue Y; Akiyoshi S; Saeki H; Oki E; Kitao H; Maehara Y
    PLoS One; 2016; 11(12):e0168090. PubMed ID: 27977754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
    Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
    DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.
    Siriwardena SU; Perera MLW; Senevirathne V; Stewart J; Bhagwat AS
    Mol Cell Biol; 2019 Jan; 39(1):. PubMed ID: 30348839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
    Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers.
    Chou WC; Chen WT; Hsiung CN; Hu LY; Yu JC; Hsu HM; Shen CY
    Sci Rep; 2017 Mar; 7():44089. PubMed ID: 28276478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for APOBEC3B mutagenesis in multiple human cancers.
    Burns MB; Temiz NA; Harris RS
    Nat Genet; 2013 Sep; 45(9):977-83. PubMed ID: 23852168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    Sieuwerts AM; Schrijver WA; Dalm SU; de Weerd V; Moelans CB; Ter Hoeve N; van Diest PJ; Martens JW; van Deurzen CH
    PLoS One; 2017; 12(1):e0171343. PubMed ID: 28141868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines.
    Onguru O; Yalcin S; Rosemblit C; Zhang PJ; Kilic S; Gunduz U
    Biomed Pharmacother; 2016 Apr; 79():87-92. PubMed ID: 27044816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.